MASLEG L

Indicated in the treatment of clinical and subclinical mastitis during lactation, caused by: Corynebacterium sp., Streptococcus sp., Staphylococcus sp., Escherichia coli, Proteus sp., Klebsiella sp., Mycoplasma sp.

Masleg L is composed of two broad spectrum bactericidal synergistic antibiotics, spiramycin and neomycin, with a synthetic glucocorticoid anti-inflammatory drug such as prednisolone; in therapeutic concentrations, for the treatment of mastitis in lactation period.

Guaranteed gomposition:

Each Syringe for 10 mL of intramammary solution contains:

• Spiramycin adipate 294 mg
  (Equivalent in spiramycin base 250 mg)
• Neomycin sulfate 296 mg
  (Equivalent to neomycin base 200 mg)
• Prednisolone sodium phosphate 6,8 mg
  (Equivalent in prednisolone base 5 mg)
• Excipients q.s. 10 mL

Route of administration:

Intramammary.

Dosage:

Thoroughly milk, clean, disinfect and dry the teat of the affected quarter; infuse the entire contents of the syringe (10 mL) by introducing the first portion of the cannula, into the duct of the nipple. Make a gentle upward massage, to ensure the distribution of the medicine. Repeat the application at the end of each of the following milkings until completing 3 – 5 applications; or at the discretion of the veterinarian.

Withdrawal time:

• Treated animals should not be sacrificed for human consumption until 16 days after the end of treatment.
• The milk produced during the treatment and 120 hours after the end of it, should not be given for human consumption.

Cautions:

• Do not administer during the last third of pregnancy.
• Store in a cool, dry place at a temperature below 25 ° C protected from sunlight.

Presentations:

Syringes x 10 mL in boxes x 4, 12, 20 and bucket of 40 units.

ICA Reg. No.: 8430-MV